FDA orphan products clinical trial grants
Executive Summary
Agency will publish request for applications (RFA) notice on FY 1994 funds expected to be granted for clinical trials on the safety and efficacy of orphan products, Aug. 18 Federal Register states. Requests to receive the RFA can be sent to Carol Wetmore, Office of Orphan Products Development (HF-35), FDA, 5600 Fishers Lane, Rm. 8-73, Rockville, Md. 20857.